Showing results (21-30 of 49) with videos related to
Sort By:
Pageof 5
Frontiers in Medicine|September 28, 2020
Pulmonary Thrombosis or Embolism in a Large Cohort of Hospitalized Patients With Covid-19Natividad Benito, David Filella, Jose Mateo, et al.Brain and Behavior|February 9, 2022
Neuropsychological deficits in patients with cognitive complaints after COVID-19Carmen García-Sánchez, Marco Calabria, Nicholas Grunden, et al.International Journal of Antimicrobial Agents|January 28, 2017
Validation of a colistin plasma concentration breakpoint as a predictor of nephrotoxicity in patients treated with colistin methanesulfonateJuan P Horcajada, Luisa Sorlí, Sonia Luque, et al.Journal of Clinical Microbiology|March 1, 2013
Epidemiology of Clostridium difficile infection and risk factors for unfavorable clinical outcomes: results of a hospital-based study in Barcelona, SpainDolors Rodríguez-Pardo, Benito Almirante, Rosa M Bartolomé, et al.Antimicrobial Agents and Chemotherapy|December 14, 2011
Prospective multicenter study of the impact of carbapenem resistance on mortality in Pseudomonas aeruginosa bloodstream infectionsCarmen Peña, Cristina Suarez, Mónica Gozalo, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 13, 2013
Effect of adequate single-drug vs combination antimicrobial therapy on mortality in Pseudomonas aeruginosa bloodstream infections: a post Hoc analysis of a prospective cohortCarmen Peña, Cristina Suarez, Alain Ocampo-Sosa, et al.Enfermedades Infecciosas Y Microbiologia Clinica (English Ed.)|April 5, 2025
Surveillance of catheter-related bacteremia in VINCat programOriol Gasch, Alexander Almendral, Marta Andrés, et al.Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|May 13, 2022
Trends in the epidemiology of catheter-related bloodstream infections; towards a paradigm shift, Spain, 2007 to 2019Laia Badia-Cebada, Judit Peñafiel, Patrick Saliba, et al.Medicine|June 9, 2021
Sarilumab (IL-6R antagonist) in critically ill patients with cytokine release syndrome by SARS-CoV2Hèctor Corominas, Ivan Castellví, César Diaz-Torné, et al.Plos One|August 8, 2024
Evolving trends in neuropsychological profiles of post COVID-19 condition: A 1-year follow-up in individuals with cognitive complaintsNicholas Grunden, Marco Calabria, Carmen García-Sánchez, et al.Pageof 5